Beth Israel Deaconess Medical Center competitive analysis

Loading summary...

Explore Beth Israel Deaconess Medical Center's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 29, 2020Antibody Therapies For Human Immunodeficiency Virus (Hiv)1

Latest publications and patents of Beth Israel Deaconess Medical Center New

Explore the latest publications and patents granted to Beth Israel Deaconess Medical Center, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Beth Israel Deaconess Medical Center

Jul 29, 2020Antibody Therapies For Human Immunodeficiency Virus (Hiv)Granted And Under Opposition
Jan 24, 2018Poly-N-Acetyl Glucosamine (Pnag/Dpnag)-Binding Peptides And Methods Of Use ThereofNo Opposition Filed Within Time Limit
Jan 10, 2018Biochemically Stabilized Hiv-1 Env Trimer VaccineNo Opposition Filed Within Time Limit
Jan 10, 2018Stimulation Of Anti-Tumor Immunity Using Dendritic Cell/Tumor Cell Fusions And Anti-Cd3/Cd28No Opposition Filed Within Time Limit

Latest PTAB cases involving Beth Israel Deaconess Medical Center

Discover the latest PTAB cases involving Beth Israel Deaconess Medical Center, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Beth Israel Deaconess Medical Center with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BETH ISRAEL DEACONESS MEDICAL CENTER - 1 - -
JAMES POOLE153 - - -